Skip to main content

Epidemiology of Cancer Recurrence, Second Primary Cancer, and Comorbidity Among Cancer Survivors

  • Chapter
  • First Online:
Health Services for Cancer Survivors

Abstract

Several definitions of cancer survivor have been proposed [1]. This chapter uses the modified National Cancer Institute (NCI) definition of cancer survivor as any one who has a history of cancer diagnosis and has completed the primary treatment. The long-term cancer survivors refer to those who have survived for 5 or more years.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Feuerstein M. Defining cancer survivorship. J Cancer Surviv. 2007;1(1):5–7.

    Article  PubMed  Google Scholar 

  2. Altekruse S, Kosary C, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner M, Lewis D, Cronin K, Chen H, Feuer E, Stinchcomb D, Edwards Be. SEER Cancer Statistics Review, 1975–2007, National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010.

  3. Curtis R, Freedman D, Ron E, Ries L, Hacker D, Edwards B, Tucker M, and Fraumeni JJe. New malignancies among cancer survivors: SEER Cancer Registries, 1973–2000. Bethesda, MD: National Cancer Institute. NIH Publ. No. 05-5302; 2006.

    Google Scholar 

  4. Yabroff KR, Lawrence WF, Clauser S, Davis WW, Brown ML. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004;96(17):1322–30.

    Article  PubMed  Google Scholar 

  5. Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001;285(7):885–92.

    Article  CAS  PubMed  Google Scholar 

  6. Yu X, McBean AM, Virnig BA. Physician visits, patient comorbidities, and mammography use among elderly colorectal cancer survivors. J Cancer Surviv. 2007;1(4):275–82.

    Article  PubMed  Google Scholar 

  7. Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci. 2003;58(1):82–91.

    Article  PubMed  Google Scholar 

  8. Hewitt M, Greenfield S, Stovall E, editors. From cancer patient to cancer suvivor: lost in transition. Washington, DC: The National Academies Press; 2006.

    Google Scholar 

  9. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572–82.

    Article  CAS  PubMed  Google Scholar 

  10. Landier W, Bhatia S. Cancer survivorship: a pediatric perspective. Oncologist. 2008;13(11):1181–92.

    Article  PubMed  Google Scholar 

  11. Robison LL, Armstrong GT, Boice JD, Chow EJ, Davies SM, Donaldson SS, et al. The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research. J Clin Oncol. 2009;27(14):2308–18.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Feuerstein M, editor. Handbook of cancer survivorship. New York: Springer; 2007, xix, 504 p.

    Google Scholar 

  13. Ganz PA, editor. Cancer survivorship, today and tomorrow. 1st ed. New York: Springer; 2007.

    Google Scholar 

  14. Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009;151(10):738–47.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Fakih MG, Padmanabhan A. CEA monitoring in colorectal cancer. What you should know. Oncol Williston Park. 2006;20(6):579–87. discussion 588, 594, 596 passim.

    Google Scholar 

  16. Crawford E, Leewansangtong S, Goktas S, Holthaus K, Baier M. Efficiency of prostate-specific antigen and digital rectal examination in screening, using 4.0 ng/ml and age-specific reference range as a cutoff for abnormal values. Prostate J. 1999;38(4):296–302.

    Article  CAS  Google Scholar 

  17. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233–41.

    Article  PubMed  Google Scholar 

  18. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687–717.

    Article  Google Scholar 

  19. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087–106.

    Article  CAS  PubMed  Google Scholar 

  20. Manfredi S, Bouvier AM, Lepage C, Hatem C, Dancourt V, Faivre J. Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg. 2006;93(9):1115–22.

    Article  CAS  PubMed  Google Scholar 

  21. Figueredo A, Rumble RB, Maroun J, Earle CC, Cummings B, McLeod R, et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer. 2003;3:26.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Han M, Partin AW, Piantadosi S, Epstein JI, Walsh PC. Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J Urol. 2001;166(2):416–9.

    Article  CAS  PubMed  Google Scholar 

  23. Kerlikowske K, Molinaro A, Cha I, Ljung BM, Ernster VL, Stewart K, et al. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. J Natl Cancer Inst. 2003;95(22):1692–702.

    Article  PubMed  Google Scholar 

  24. Evans CP. Follow-up surveillance strategies for genitourinary malignancies. Cancer. 2002;94(11):2892–905.

    Article  PubMed  Google Scholar 

  25. Baker F, Denniston M, Smith T, West MM. Adult cancer survivors: how are they faring? Cancer. 2005;104(11 Suppl):2565–76.

    Article  PubMed  Google Scholar 

  26. Deimling GT, Bowman KF, Sterns S, Wagner LJ, Kahana B. Cancer-related health worries and psychological distress among older adult, long-term cancer survivors. Psychooncology. 2006;15(4):306–20.

    Article  PubMed  Google Scholar 

  27. Anderson SJ, Wapnir I, Dignam JJ, Fisher B, Mamounas EP, Jeong JH, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol. 2009;27(15):2466–73.

    Article  PubMed Central  PubMed  Google Scholar 

  28. Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol. 2006;24(15):2268–75.

    Article  PubMed  Google Scholar 

  29. Renehan AG, Egger M, Saunders MP, O’Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ. 2002;324(7341):813.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Snyder CF, Earle CC, Herbert RJ, Neville BA, Blackford AL, Frick KD. Trends in follow-up and preventive care for colorectal cancer survivors. J Gen Intern Med. 2008;23(3):254–9.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Ganz PA. Survivorship: adult cancer survivors. Prim Care. 2009;36(4):721–41.

    Article  PubMed  Google Scholar 

  32. Travis LB. The epidemiology of second primary cancers. Cancer Epidemiol Biomark Prev. 2006;15(11):2020–6.

    Article  Google Scholar 

  33. Travis LB, Rabkin CS, Brown LM, Allan JM, Alter BP, Ambrosone CB, et al. Cancer survivorship–genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst. 2006;98(1):15–25.

    Article  PubMed  Google Scholar 

  34. Ng AK, Travis LB. Second primary cancers: an overview. Hematol Oncol Clin North Am. 2008;22(2):271–89. vii.

    Article  PubMed  Google Scholar 

  35. Mariotto AB, Rowland JH, Ries LA, Scoppa S, Feuer EJ. Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomark Prev. 2007;16(3):566–71.

    Article  Google Scholar 

  36. Travis LB, Fossa SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, et al. Second cancers among 40, 576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst. 2005;97(18):1354–65.

    Article  PubMed  Google Scholar 

  37. Tward J, Glenn M, Pulsipher M, Barnette P, Gaffney D. Incidence, risk factors, and pathogenesis of second malignancies in patients with non-Hodgkin lymphoma. Leuk Lymphoma. 2007;48(8):1482–95.

    Article  PubMed  Google Scholar 

  38. Chaturvedi AK, Engels EA, Gilbert ES, Chen BE, Storm H, Lynch CF, et al. Second cancers among 104, 760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst. 2007;99(21):1634–43.

    Article  PubMed  Google Scholar 

  39. Henderson TO, Amsterdam A, Bhatia S, Hudson MM, Meadows AT, Neglia JP, et al. Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med. 2010;152(7):444–55. W144-54.

    Article  PubMed Central  PubMed  Google Scholar 

  40. Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst. 1994;86(7):527–37.

    Article  CAS  PubMed  Google Scholar 

  41. Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Manson JE, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA. 1997;278(17):1407–11.

    Article  CAS  PubMed  Google Scholar 

  42. Bergstrom A, Pisani P, Tenet V, Wolk A, Adami HO. Overweight as an avoidable cause of cancer in Europe. Int J Cancer. 2001;91(3):421–30.

    Article  CAS  PubMed  Google Scholar 

  43. Kushi LH, Kwan ML, Lee MM, Ambrosone CB. Lifestyle factors and survival in women with breast cancer. J Nutr. 2007;137(1 Suppl):236S–42.

    CAS  PubMed  Google Scholar 

  44. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA. 2001;285(21):2750–6.

    Article  CAS  PubMed  Google Scholar 

  45. Walter LC, Lewis CL, Barton MB. Screening for colorectal, breast, and cervical cancer in the elderly: a review of the evidence. Am J Med. 2005;118(10):1078–86.

    Article  PubMed  Google Scholar 

  46. Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chron Dis. 1970;23(7):455–68.

    Article  Google Scholar 

  47. Boyd CM, Weiss CO, Halter J, Han KC, Ershler WB, Fried LP. Framework for evaluating disease severity measures in older adults with comorbidity. J Gerontol A Biol Sci Med Sci. 2007;62(3):286–95.

    Article  PubMed  Google Scholar 

  48. Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7(4):357–63.

    Article  PubMed Central  PubMed  Google Scholar 

  49. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59(3):255–63.

    Article  PubMed  Google Scholar 

  50. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40(5):373–83.

    Article  CAS  PubMed  Google Scholar 

  51. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–9.

    Article  CAS  PubMed  Google Scholar 

  52. Satariano WA, Silliman RA. Comorbidity: implications for research and practice in geriatric oncology. Crit Rev Oncol Hematol. 2003;48(2):239–48.

    Article  PubMed  Google Scholar 

  53. Karlamangla A, Tinetti M, Guralnik J, Studenski S, Wetle T, Reuben D. Comorbidity in older adults: nosology of impairment, diseases, and conditions. J Gerontol A Biol Sci Med Sci. 2007;62(3):296–300.

    Article  PubMed  Google Scholar 

  54. Pope GC, Kautter J, Ellis RP, Ash AS, Ayanian JZ, Lezzoni LI, et al. Risk adjustment of Medicare capitation payments using the CMS-HCC model. Health Care Financ Rev. 2004;25(4):119–41.

    PubMed  Google Scholar 

  55. Elixhauser A, Steiner C, Palmer L, Clinical classifications software (CCS), 2010. U.S. Agency for Healthcare Research and Quality. Available: http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp.

  56. Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, van den Bos GA. Causes and consequences of comorbidity: a review. J Clin Epidemiol. 2001;54(7):661–74.

    Article  CAS  PubMed  Google Scholar 

  57. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162(20):2269–76.

    Article  PubMed  Google Scholar 

  58. Mao JJ, Armstrong K, Bowman MA, Xie SX, Kadakia R, Farrar JT. Symptom burden among cancer survivors: impact of age and comorbidity. J Am Board Fam Med. 2007;20(5):434–43.

    Article  PubMed  Google Scholar 

  59. Keating NL, Norredam M, Landrum MB, Huskamp HA, Meara E. Physical and mental health status of older long-term cancer survivors. J Am Geriatr Soc. 2005;53(12):2145–52.

    Article  PubMed  Google Scholar 

  60. Ness KK, Hudson MM, Ginsberg JP, Nagarajan R, Kaste SC, Marina N, et al. Physical performance limitations in the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009;27(14):2382–9.

    Article  PubMed Central  PubMed  Google Scholar 

  61. Janson C, Leisenring W, Cox C, Termuhlen AM, Mertens AC, Whitton JA, et al. Predictors of marriage and divorce in adult survivors of childhood cancers: a report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomark Prev. 2009;18(10):2626–35.

    Article  Google Scholar 

  62. Garman KS, Pieper CF, Seo P, Cohen HJ. Function in elderly cancer survivors depends on comorbidities. J Gerontol A Biol Sci Med Sci. 2003;58(12):M1119–24.

    Article  PubMed  Google Scholar 

  63. Lazovich D, Robien K, Cutler G, Virnig B, Sweeney C. Quality of life in a prospective cohort of elderly women with and without cancer. Cancer. 2009;115(18 Suppl):4283–97.

    Article  PubMed Central  PubMed  Google Scholar 

  64. Sweeney C, Schmitz KH, Lazovich D, Virnig BA, Wallace RB, Folsom AR. Functional limitations in elderly female cancer survivors. J Natl Cancer Inst. 2006;98(8):521–9.

    Article  PubMed  Google Scholar 

  65. Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005;294(14):1765–72.

    Article  CAS  PubMed  Google Scholar 

  66. Lash TL, Mor V, Wieland D, Ferrucci L, Satariano W, Silliman RA. Methodology, design, and analytic techniques to address measurement of comorbid disease. J Gerontol A Biol Sci Med Sci. 2007;62(3):281–5.

    Article  PubMed Central  PubMed  Google Scholar 

  67. Earle CC, Neville BA, Fletcher R. Mental health service utilization among long-term cancer survivors. J Cancer Surviv. 2007;1(2):156–60.

    Article  PubMed  Google Scholar 

  68. Kerr EA, Heisler M, Krein SL, Kabeto M, Langa KM, Weir D, et al. Beyond comorbidity counts: how do comorbidity type and severity influence diabetes patients’ treatment priorities and self-management? J Gen Intern Med. 2007;22(12):1635–40.

    Article  PubMed Central  PubMed  Google Scholar 

  69. Jaen CR, Stange KC, Nutting PA. Competing demands of primary care: a model for the delivery of clinical preventive services. J Fam Pract. 1994;38(2):166–71.

    CAS  PubMed  Google Scholar 

  70. National Committee for Quality Assurance (NCQA). Patient-Centered Medical Home. [cited 2010 05/07]; Available from: http://www.ncqa.org/tabid/631/Default.aspx.

  71. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294(6):716–24.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xinhua Yu .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Yu, X. (2011). Epidemiology of Cancer Recurrence, Second Primary Cancer, and Comorbidity Among Cancer Survivors. In: Feuerstein, M., Ganz, P. (eds) Health Services for Cancer Survivors. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1348-7_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1348-7_14

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1347-0

  • Online ISBN: 978-1-4419-1348-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics